Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks ...

Nearly 3.9 million people in England and Wales receive PIP - these are the health conditions most likely to receive ongoing payments ...

PIP and ADP payments currently range from £29.20 to £187.45 per week, equivalent to £116.80 or £749.80 every four-week pay ...

The data also shows that more than 1.5m (39%) of all PIP claimants have been issued with an award of five years or longer. More than 58 per cent of people claiming PIP for a visual condition have a ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of ...

The disability accommodation new build program is worth about $4 billion so far, dominated by a handful of big investment ...

NuWatt Lighting, a premier residental and commercial lighting brand, has announced the launch of a new family of under cabinet LED lights, reinforcing the company's broader commitment to quality, ...

Appealing an insurance claim denial with multiple sclerosis often requires following the rules and being persistent.

The actress, whose new memoir is out next month, jokes that she rates the disease "zero stars," adding, "Would not recommend" ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases, today announced the presentation of ...